Stocks In Motion

Health Stocks in Motion

 

Updated from 2:27 p.m. EST

Shares of Kendle International(KNDL) were among the best-performing health-related stocks Monday, rising 35.8% after the clinical research organization posted big gains in fourth-quarter earnings and sales.

The company earned $2.1 million, or 16 cents a share, on net service sales of $48 million. One analyst polled by Thomson First Call was expecting earnings of 9 cents a share. A year ago the company earned $513,000, or 4 cents a share, on sales of $40.1 million. For the full year, Kendle earned $3.6 million, or 27 cents a share, on sales of $172.9 million. During 2003, the company posted a loss of $1.7 million, or 13 cents a share, on sales of $156.2 million. Shares traded up $2.69 to $10.20.

Discovery Laboratories(DSCO) rose 10.9% after the company said the Food and Drug Administration tentatively approved its Surfaxin drug for use in preventing respiratory distress syndrome in premature infants. The company still needs to finalize labeling and correct previously reported manufacturing issues, but the FDA is not requiring any additional trials for final approval, the company said. Discovery Labs said that it expects to launch the drug, pending final FDA approval, during the fourth quarter of 2005 or the first quarter of 2006. Shares traded up 63 cents to $6.42.

Shares of Encysive Pharmaceuticals(ENCY) rose 12.3% after the company said that a late-stage trial of its Thelin drug met its primary endpoint of improved six-minute-walk distance when compared with a placebo. A 50-milligram dose of Thelin improved the six-minute-walk distance by 24.2 meters and bosentan, currently the only approved treatment for pulmonary arterial hypertension, improved the walk distance by 29.5 meters. Patients taking a 100 milligram dose of Thelin improved their walk distance by 31.4 meters when compared with a placebo. The company said that it would now focus on filing a new drug application with the FDA in April 2005 so that it could gain marketing approval. Shares traded up $1.29 to $11.80.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,393.45 1,310.33 2,827.34 15.81
Oil *
101.78
DOWN
26.41
DOWN
2.99
DOWN
10.02
DOWN
0.44
10 Yr
1.58%
SPDR Gold
151.62
-0.21%
-0.23%
-0.35%
-2.71%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet